跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
BLIZOMIT 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIÓN - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
BLIZOMIT 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIÓN
Approved
STANDARD
BLIZOMIT 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIÓN
Pharmathen S.A.
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 9, 2024
Approval ID
371abdf7ae362df5
Company
Pharmathen S.A.
Type
Standard
Approval Details
Approval Id
371abdf7ae362df5
Drug Cima Aemps Name
BLIZOMIT 10 MG/ML + 5 MG/ML COLIRIO EN SUSPENSIÓN
Register Number
89314
Holder Company Name
Pharmathen S.A.
Marketing Company Name
Pharmathen S.A.
Holder Company Detail Path
/organization/pharmathen-s-a
Marketing Company Detail Path
/organization/pharmathen-s-a
Authorization Date
2024-02-09
Dosage Form
COLIRIO EN SUSPENSIÓN
Dose
10 mg/ml + 5 mg/ml
Route Of Administration
VÍA OFTÁLMICA
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Pharmathen S.A.
Company Detail Path
/organization/pharmathen-s-a
Company Information
Pharmaceutical Company Name
PHARMATHEN S.A.
Country Name
Greece
City Name
pallini,sterea ellada and evoia,country_gr
Address
6 Dervenakion
Active Ingredients
BRINZOLAMIDA
10 mg/ml
TIMOLOL MALEATO
6,830 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 9, 2024
Approval ID
371abdf7ae362df5
Type
Standard
Back to CIMA-AEMPS Approvals
